Enhanced Recovery After Surgery: Optimizing Perioperative Patient Care

Tuesday, October 1, 2024

12:30 PM – 1:30 PM EDT

Location: MBCC, 203-205

CME/MOC Credit: 1

Disclosure(s):

Carol M. Lewis, MD MPH:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Carol M. Bier-Laning, MD, MBA:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Karthik Rajasekaran, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: In recent years, there has been increased scrutiny of specific post-operative metrics by hospital administrators and payers. Surgeons-led quality improvement initiatives have contributed to reduced hospital length of stay, readmission rates, and post-operative complications with implications for patient satisfaction and fiscal stewardship. Enhanced Recovery After Surgery (ERAS) programs is one such quality initiative, with the ultimate goal of expedited recovery of patients. ERAS programs rely on interdisciplinary coordination to optimize patient nutrition, antibiotic prophylaxis, thrombo-prophylaxis, and pain control, amongst other factors, through standardized and evidence-based care pathways to achieve early mobilization and faster recovery. Importantly, these protocols utilize multimodal analgesia strategies to minimize opioid use. These strategies have obvious implications for patient safety and quality improvement as well as for addressing our national opioid crisis.

This panel discussion will focus on informing otolaryngologists about the emerging literature on ERAS in otolaryngology-head and neck surgery, with opioid-sparing multimodal analgesia as an essential component. Speakers will describe the benefits of ERAS and strategies for its adoption into practice for otolaryngology patients, with discussion of both head and neck surgery-specific protocols and programs that include all otolaryngology subspecialties. Furthermore, discussion will include the methods for monitoring compliance and outcomes. Audience members will have the opportunity to choose specific ERAS interventions for further discussion.

Learning Objectives:

Describe the rationale and role of enhanced recovery pathways in otolaryngology-head and neck surgery.
Identify multimodal analgesia as an alternative to opioid analgesia in otolaryngology-head and neck surgery.
Understand strategies for introducing enhanced recovery and multimodal analgesia into practice and for monitoring progress through compliance and outcomes.

Moderator(s)

Aru Panwar, MD

Associate Professor, Head & Neck Surgical Oncology
Methodist Estabrook Cancer Center & Creighton University School of Medicine
Omaha, Nebraska, United States

Disclosure information not submitted.
CL

Carol M. Lewis, MD MPH

Professor
MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

CL

Carol M. Lewis, MD MPH

Professor
MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Carol M. Bier-Laning, MD, MBA

Professor Emerita
Dept of Otolaryngology, Loyola University Medical Center
Maywood, IL, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Karthik Rajasekaran, MD

Associate Professor, Head and Neck Oncologic & Reconstructive Surgeon, Director of QI
Department of Otorhinolaryngology Head and Neck Surgery, Hospital of the University of Pennsylvania
Philadelphia, PA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.